$ONEW

OneWater Marine Inc. (ONEW): Results of Operations and Financial Condition

OneWater Marine Inc. (ONEW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 onew-q326earningsreleasexe.htm EX-99.1 Document Exhibit 99.1 OneWater Marine Inc. Announces Fiscal Third Quarter 2026 Results Delivered Margin Expansion, Continued Debt Reduction, and Improved Profitability Fiscal Third Quarter 2026 Highlights • Revenue decreased 4% to

Original reporting
Published Jul 30, 2026, 11:01 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 11:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ONEW
Neutral
medium confidence
Mentioned
$ONEW
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ONEWNeutralMed
01

Why it matters

Traders can reprice the stock based on the combination of (1) margin expansion, (2) faster-than-expected leverage target achievement, and (3) revised FY2026 revenue, EBITDA, and adjusted EPS ranges under a down-industry assumption.

02

Market read

The filing provides fresh, decision-useful guidance ranges and balance-sheet metrics, not just commentary.

03

What to watch

Service, parts & other revenue fell 12.8% and adjusted EPS guidance is broad ($0.35 to $0.55), implying execution and demand uncertainty into Q4.

Relevance 7/10Novelty 8/10Timing: today, pre-market filing of Q3 results and revised FY2026 outlook

Background

This is an SEC 8-K (Item 2.02) with OneWater’s fiscal third quarter ended June 30, 2026 results and an updated full-year 2026 outlook.

Company-level read

Ticker impact

$ONEWNeutralMedium confidence
Context

OneWater reported fiscal Q3 results and updated FY2026 guidance, including revenue $1.75B to $1.80B and adjusted EPS $0.35 to $0.55.

Expected impact

Near-term bias likely modestly positive on margin/leverage, but tempered by lower revenue and wide EPS range.

Evidence & confidence

The filing discloses both improved gross margin (+70 bps) and net debt leverage (3.7x vs 5.8x), while total revenue fell 4% and service/parts declined 12.8%, with FY2026 guidance reflecting a down high-single-digit industry backdrop.

Market effects

Signals continued pressure in retail marine demand while operators focus on margin and balance-sheet deleveraging.

No specific regional read-through beyond US retail marine conditions.

Limited global relevance; impacts are primarily within the US marine retail and dealership ecosystem.

Counterpoint

The leverage improvement may be partly mechanical from divestiture and mix shifts, so operating momentum could be less durable than the headline suggests.

Key entities

  • OneWater Marine Inc.

    Reports fiscal Q3 2026 results and updates FY2026 guidance, including revenue $1.75B to $1.80B and adjusted EPS $0.35 to $0.55.

  • Ocean Bio-Chem (OBCI) divestiture

    Cited as a driver of lower revenue and service/parts decline in Q3, and as a factor in improved leverage.

Related articles

$ONEWMedAI 8/10

OneWater Marine Q3 Earnings Call Highlights

OneWater Marine (NASDAQ:ONEW) reported Q3 gross profit of $127M and gross margin of 24%, citing pricing and product mix. SG&A fell 5% to $87M. Cash was $69M, long-term debt $348M, and adjusted net leverage dropped to 3.7x. Outlook: revenue $1.75B-$1.8B, adj. EBITDA $68M-$78M, adj. EPS $0.35-$0.55; marine industry seen down high single digits.

$ONEWMedAI 8/10

OneWater Marine: Fiscal Q3 Earnings Snapshot

OneWater Marine Inc. (ONEW) reported fiscal Q3 earnings of $11.7 million, or 69 cents per share. Adjusted earnings were 73 cents per share. Revenue was $530.7 million. The company forecast full-year earnings of 35 to 55 cents per share and revenue of $1.75 billion to $1.8 billion, according to the company.

$NVOMedAI 8/10

Novo Nordisk A/S Q2 Earnings Call Highlights

Novo Nordisk reported Q2 adjusted sales of DKK 78.5 billion, with obesity care sales up 16% and GLP-1 diabetes up 2%. Adjusted gross margin fell to 78.2% from 82.7% due to lower prices, about DKK 3 billion one-time manufacturing-cost items, and FX. The company raised 2026 outlook to 0% to -6% adjusted sales and operating profit growth. ZEUS ziltivekimab trial missed its primary endpoint (HR 0.99).

$NYTMed

New York Times Q2 Earnings Call Highlights

The New York Times Company (NYSE:NYT) reported Q2 results on its earnings call. Digital-only subscribers rose 13.3% YoY and digital-only ARPU increased 3.1%. First-half free cash flow was about $266M and the company returned about $160M to shareholders. It guided Q3 digital-only subscription revenue up 12% to 15% and digital ad revenue up mid- to high-teens.

$OCMed

Owens Corning Q2 Earnings Call Highlights

Owens Corning (NYSE:OC) said Iran-related net cost impact is expected to be about $40 million in Q3, with roofing the most affected segment. The company reported Q2 liquidity of $1.8 billion and plans to repay $400 million of senior notes in Q3. Full-year capex is about $800 million. Roofing Q2 sales were ~$1.3 billion; insulation revenue rose 4% to $971 million.